Cargando…

Targeting the TAM Receptors in Leukemia

Targeted inhibition of members of the TAM (TYRO-3, AXL, MERTK) family of receptor tyrosine kinases has recently been investigated as a novel strategy for treatment of hematologic malignancies. The physiologic functions of the TAM receptors in innate immune control, natural killer (NK) cell different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huey, Madeline G., Minson, Katherine A., Earp, H. Shelton, DeRyckere, Deborah, Graham, Douglas K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126761/ https://www.ncbi.nlm.nih.gov/pubmed/27834816 http://dx.doi.org/10.3390/cancers8110101

Ejemplares similares

Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
por: Yan, Dan, et al.
Publicado: (2021)

The Current State of FLT3 Inhibition in Acute Myeloid Leukemia – Pitfalls and Promises
por: Minson, Katherine A, et al.
Publicado: (2017)

MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity
por: Lee-Sherick, Alisa B., et al.
Publicado: (2020)

Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer
por: Cummings, Christopher T., et al.
Publicado: (2014)

The Emerging Role of TYRO3 as a Therapeutic Target in Cancer
por: Smart, Sherri K., et al.
Publicado: (2018)

Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia
por: Summers, Ryan J., et al.
Publicado: (2022)

UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
por: Zhang, Weihe, et al.
Publicado: (2014)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

Bioluminescence imaging of leukemia cell lines in vitro and in mouse xenografts: effects of monoclonal and polyclonal cell populations on intensity and kinetics of photon emission
por: Christoph, Sandra, et al.
Publicado: (2013)

Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia
por: Lee-Sherick, Alisa B., et al.
Publicado: (2015)

Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus
por: Migdall-Wilson, Justine, et al.
Publicado: (2012)

Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
por: Lee-Sherick, A B, et al.
Publicado: (2013)

Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
por: Lee-Sherick, A B, et al.
Publicado: (2016)

MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme
por: Sufit, Alexandra, et al.
Publicado: (2016)

MERTK activation drives osimertinib resistance in EGFR-mutant non–small cell lung cancer
por: Yan, Dan, et al.
Publicado: (2022)

Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia
por: Lee, Miyoung, et al.
Publicado: (2022)

TAM receptors in cardiovascular disease
por: McShane, Lucy, et al.
Publicado: (2019)

Association of race/ethnicity with innate immune tumor microenvironment of children with B-acute lymphoblastic leukemia
por: Gilbert, Julie R, et al.
Publicado: (2022)

TAM receptors, Phosphatidylserine, inflammation, and Cancer
por: Burstyn-Cohen, Tal, et al.
Publicado: (2019)

Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
por: Lew, Erin D, et al.
Publicado: (2014)

Diversification of TAM receptor function
por: Zagórska, Anna, et al.
Publicado: (2014)

Two-Front War on Cancer—Targeting TAM Receptors in Solid Tumour Therapy
por: Mikolajczyk, Agata, et al.
Publicado: (2022)

TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration
por: Tondo, Giacomo, et al.
Publicado: (2019)

TAM Receptor Inhibition–Implications for Cancer and the Immune System
por: Aehnlich, Pia, et al.
Publicado: (2021)

Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors
por: Hedrich, Viola, et al.
Publicado: (2021)

Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
por: Zhou, Yunxiang, et al.
Publicado: (2021)

Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis
por: Bhasin, Swati S., et al.
Publicado: (2023)

Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia
por: Brandao, L N, et al.
Publicado: (2013)

Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia
por: Mumme, Hope L., et al.
Publicado: (2023)

Gas6/TAM Receptors in Systemic Lupus Erythematosus
por: Cohen, Philip L., et al.
Publicado: (2019)

TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
por: Schmitz, Robin, et al.
Publicado: (2016)

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
por: Myers, Kayla V., et al.
Publicado: (2019)

Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects
por: Peters, Solange, et al.
Publicado: (2022)

The Dual Role of TAM Receptors in Autoimmune Diseases and Cancer: An Overview
por: Wium, Martha, et al.
Publicado: (2018)

GAS6/TAM Pathway Signaling in Hemostasis and Thrombosis
por: Law, Luke A., et al.
Publicado: (2018)

Targeting Gas6/TAM in cancer cells and tumor microenvironment
por: Wu, Guiling, et al.
Publicado: (2018)

TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy
por: Dayoub, Adam S., et al.
Publicado: (2020)

Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response
por: Davra, Viralkumar, et al.
Publicado: (2016)

The TAM family as a therapeutic target in combination with radiation therapy
por: Tormoen, Garth W., et al.
Publicado: (2017)

Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders
por: Gadiyar, Varsha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ig3nbkp06smql0c9kk3mf0uipa